CAPZA2 and amyotrophic lateral sclerosis: Although ALDH16A1 (ALS: 0.08, IQR: -0.27, 0.50; controls: 0.18, IQR: -0.20, 0.56; padj = 0.432), CAPZA2 (ALS: 0.05, IQR: -0.26, 0.38; controls: 0.29, IQR: -0.40, 0.47; padj = 0.636), and PFKL (ALS: 0.13, IQR: -0.08, 0.68; controls: 0.27, IQR: -0.01, 0.64; padj = 0.629) showed numerically lower abundance in ALS, these differences were not statistically significant.